Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Repositori Institucional UIB
Publicación Artículo científico (JournalArticle)

Impact of a Longer-Term Physical Activity Intervention on Inflammatory and Oxidative Stress Biomarkers in Older People with Metabolic Syndrome

  • Quetglas-Llabrés, Maria Magdalena
  • Monserrat-Mesquida, Margalida
  • García, Silvia
  • Ródenas-Munar, Marina
  • Mateos, David
  • Ugarriza, Lucía
  • Gómez, Cristina
  • Sureda, Antoni
  • Bouzas, Cristina
  • Tur, Josep A.
[eng] Metabolic syndrome (MetS) is characterised by cardiometabolic risk factors and is closelyassociated with increased oxidative stress and chronic low-grade inflammation. MetS islargely driven by adverse lifestyle behaviours, particularly physical inactivity, and regularphysical activity is recognised as a central strategy for its prevention and management.This study aimed to assess the long-term impact of a five-year follow-up period of physicalactivity on oxidative stress, inflammatory biomarkers, and cardiometabolic health in adultswith MetS. Forty participants diagnosed with MetS (50% men, aged 55–75 years) were selectedand stratified into two groups: those who increased their physical activity and thosewho reduced it during the intervention. Physical activity was assessed using metabolicequivalent task minutes per week (MET°§min/week), and evaluations were performedat baseline, 3 years, and 5 years. Participants who increased physical activity showeda progressive reduction in reactive oxygen species (ROS) produced by peripheral bloodmononuclear cells (PBMCs), together with a decrease in plasma malondialdehyde (MDA).Antioxidant enzyme activities, including catalase and superoxide dismutase, exhibited afavourable long-term profile, with recovery or maintenance of higher activity levels bythe end of follow-up, reflecting enhanced endogenous antioxidant defence. Inflammatorystatus improved and was characterised by a reduction in myeloperoxidase (MPO)activity and a sustained increase in plasma interleukin-15 (IL-15). These participants alsoshowed reductions in body weight, body mass index (BMI), waist circumference, fastingglucose, and glycosylated haemoglobin A1c (HbA1c), consistent with improved insulinsensitivity and metabolic control. Participants who reduced physical activity tended toshow unfavourable trajectories in several biomarkers. Increasing physical activity overtime is associated with substantial improvements in redox balance, inflammatory status,and cardiometabolic health in adults with MetS. These findings reinforce the central role ofphysical activity as a fundamental therapeutic component within lifestyle interventionsaimed at mitigating metabolic dysfunction and preventing MetS progression.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55 - IL6ST Gene Region in Immature Dendritic Cells

  • Mena, Jorge|||0009-0001-4524-205X
  • Alloza, Iraide
  • Tulloch Navarro, Raquel
  • Aldekoa, Ane
  • Díez García, Javier
  • Villanueva Etxebarria, Ane
  • Lindskog, Cecilia
  • Antigüedad, Alfredo
  • Boyero, Sabas|||0000-0003-0383-0256
  • Mendibe-Bilbao, María del Mar
  • Álvarez de Arcaya, Amaya
  • Sánchez Menoyo, José Luis|||0000-0003-2634-8294
  • Midaglia, Luciana|||0000-0001-7981-2228
  • Villarrubia, Noelia
  • Malhotra, Sunny|||0000-0003-1112-7739
  • Montalban, Xavier|||0000-0002-0098-9918
  • Villar, Luisa M.|||0000-0002-9067-3668
  • Comabella López, Manuel|||0000-0002-2373-6657
  • Vandenbroeck, Koen|||0000-0002-6967-6485
Intronic single-nucleotide polymorphisms (SNPs) in the ANKRD55 gene are associated with the risk for multiple sclerosis (MS) and rheumatoid arthritis by genome-wide association studies (GWAS). The risk alleles have been linked to higher expression levels of ANKRD55 and the neighboring IL6ST (gp130) gene in CD4 + T lymphocytes of healthy controls. The biological function of ANKRD55, its role in the immune system, and cellular sources of expression other than lymphocytes remain uncharacterized. Here, we show that monocytes gain capacity to express ANKRD55 during differentiation in immature monocyte-derived dendritic cells (moDCs) in the presence of interleukin (IL)-4/granulocyte-macrophage colony-stimulating factor (GM-CSF). ANKRD55 expression levels are further enhanced by retinoic acid agonist AM580 but downregulated following maturation with interferon (IFN)-γ and lipopolysaccharide (LPS). ANKRD55 was detected in the nucleus of moDC in nuclear speckles. We also analyzed the adjacent IL6ST, IL31RA, and SLC38A9 genes. Of note, in healthy controls, MS risk SNP genotype influenced ANKRD55 and IL6ST expression in immature moDC in opposite directions to that in CD4 + T cells. This effect was stronger for a partially correlated SNP, rs13186299, that is located, similar to the main MS risk SNPs, in an ANKRD55 intron. Upon analysis in MS patients, the main GWAS MS risk SNP rs7731626 was associated with ANKRD55 expression levels in CD4 + T cells. MoDC-specific ANKRD55 and IL6ST mRNA levels showed significant differences according to the clinical form of the disease, but, in contrast to healthy controls, were not influenced by genotype. We also measured serum sgp130 levels, which were found to be higher in homozygotes of the protective allele of rs7731626. Our study characterizes ANKRD55 expression in moDC and indicates monocyte-to-dendritic cell (Mo-DC) differentiation as a process potentially influenced by MS risk SNPs.